Daiying Zuo

发表

Alcohol amplifies ketamine-induced apoptosis in primary cultured cortical neurons and PC12 cells through down-regulating CREB-related signaling pathways

Daiying Zuo, F. Sun, Jiahui Cui, 2017, Scientific Reports.

Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma.

Daiying Zuo, Zi Liu, Zengqiang Li, 2020, International immunopharmacology.

Silver nanoparticles induce protective autophagy via Ca2+/CaMKKβ/AMPK/mTOR pathway in SH-SY5Y cells and rat brains

Daiying Zuo, Xuejiao Zhou, Zengqiang Li, 2019, Nanotoxicology.

Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2017, Toxicology in vitro : an international journal published in association with BIBRA.

COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma.

Daiying Zuo, Zengqiang Li, Weige Zhang, 2014, Biochemical and biophysical research communications.

DAT-230, a Novel Microtubule Inhibitor, Induced Aberrant Mitosis and Apoptosis in SGC-7901 Cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2013, Biological & pharmaceutical bulletin.

Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.

Daiying Zuo, Zi Liu, Zengqiang Li, 2022, Toxicology and applied pharmacology.

CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.

X. Zhai, Daiying Zuo, Zi Liu, 2018, Cancer letters.

3‐(3‐Methoxyphenyl)‐6‐(3‐amino‐4‐methoxyphenyl)‐7H‐[1,2,4] triazolo [3,4‐b][1,3,4] thiadiazine, a novel tubulin inhibitor, evokes G2/M cell cycle arrest and apoptosis in SGC‐7901 and HeLa cells

Daiying Zuo, Zi Liu, Zengqiang Li, 2020, Journal of cellular biochemistry.

Design, synthesis and anticancer activity of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-1,2,3-thiadiazoles as microtubule-destabilizing agents.

Kai Bao, Daiying Zuo, Yingliang Wu, 2020, Bioorganic chemistry.

Design, synthesis and bio-evaluation of novel 2-aryl-4-(3,4,5-trimethoxy-benzoyl)-5-substituted-1,2,3-triazoles as the tubulin polymerization inhibitors.

Kai Bao, Daiying Zuo, Yingliang Wu, 2019, European journal of medicinal chemistry.

Synthesis and bioevaluation of diarylpyrazoles as antiproliferative agents.

Kai Bao, Daiying Zuo, Yingliang Wu, 2019, European journal of medicinal chemistry.

3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation.

Kai Bao, Daiying Zuo, Yingliang Wu, 2019, European journal of medicinal chemistry.

Synthesis and bioevaluation of N,4-diaryl-1,3-thiazole-2-amines as tubulin inhibitors with potent antiproliferative activity

Jian Wang, Kai Bao, Daiying Zuo, 2017, PloS one.

Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site

X. Zhai, Nan Jiang, Daiying Zuo, 2017, Scientific Reports.

Design and synthesis of 5-aryl-4-(4-arylpiperazine-1-carbonyl)-2H-1,2,3-triazole derivatives as colchicine binding site inhibitors

Kai Bao, Daiying Zuo, Yingliang Wu, 2017, Scientific Reports.

Synthesis and antiproliferative activity of 2-aryl-4-(3,4,5-trimethoxybenzoyl)-1,2,3-triazol derivatives as microtubule-destabilizing agents

Kai Bao, Daiying Zuo, Yingliang Wu, 2017 .

Synthesis and Bioevaluation of 3,6-Diaryl-[1,2,4]triazolo[4,3-b] Pyridazines as Antitubulin Agents.

Kai Bao, Daiying Zuo, Yingliang Wu, 2016, ACS medicinal chemistry letters.

Microwave-assisted synthesis and biological evaluation of 3,4-diaryl maleic anhydride/N-substituted maleimide derivatives as combretastatin A-4 analogues.

Nan Jiang, Kai Bao, Daiying Zuo, 2015, Bioorganic & medicinal chemistry letters.

Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity

Daiying Zuo, Yingliang Wu, Xuewei Jiang, 2015, PloS one.

Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity.

Jun Zhao, S. Peng, Daiying Zuo, 2011, European journal of pharmacology.

Conditioned fear stress combined with single-prolonged stress: A new PTSD mouse model

Daiying Zuo, Yingliang Wu, B. He, 2012, Neuroscience Research.

One pot synthesis of highly luminescent polyethylene glycol anchored carbon dots functionalized with a nuclear localization signal peptide for cell nucleus imaging.

Lei Yang, Li Yang, Lipeng Qiu, 2015, Nanoscale.

Alcohol aggravates ketamine-induced behavioral, morphological and neurochemical alterations in adolescent rats: The involvement of CREB-related pathways

Daiying Zuo, Yumiao Liu, Zi Liu, 2018, Behavioural Brain Research.

Acetaldehyde Induces Neurotoxicity In Vitro via Oxidative Stress- and Ca2+ Imbalance-Mediated Endoplasmic Reticulum Stress

Daiying Zuo, Zi Liu, Xuejiao Zhou, 2019, Oxidative medicine and cellular longevity.

Titanium dioxide nanoparticles induce mouse hippocampal neuron apoptosis via oxidative stress- and calcium imbalance-mediated endoplasmic reticulum stress.

Daiying Zuo, Xuejiao Zhou, Zengqiang Li, 2018, Environmental toxicology and pharmacology.

The novel ALK inhibitor ZX‐29 induces apoptosis through inhibiting ALK and inducing ROS‐mediated endoplasmic reticulum stress in Karpas299 cells

X. Zhai, Daiying Zuo, Xuejiao Zhou, 2020, Journal of biochemical and molecular toxicology.

Existence of glia mitigated ketamine-induced neurotoxicity in neuron-glia mixed cultures of neonatal rat cortex and the glia-mediated protective effect of 2-PMPA.

Daiying Zuo, F. Sun, Zengqiang Li, 2014, Neurotoxicology.

Amphipathic silica nanoparticles induce cytotoxicity through oxidative stress mediated and p53 dependent apoptosis pathway in human liver cell line HL-7702 and rat liver cell line BRL-3A.

W. Dai, Daiying Zuo, Zengqiang Li, 2016, Colloids and surfaces. B, Biointerfaces.

The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.

Daiying Zuo, Xiaobo Xu, Xue Zhang, 2022, International immunopharmacology.

1-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)-3-(2-(dimethylamino)ethyl)imidazolidin-2-one (ZX-42) inhibits cell proliferation and induces apoptosis via inhibiting ALK and its downstream pathways in Karpas299 cells.

X. Zhai, Jiang Bian, Daiying Zuo, 2022, Toxicology and applied pharmacology.

Baicalin Attenuates Ketamine-Induced Neurotoxicity in the Developing Rats: Involvement of PI3K/Akt and CREB/BDNF/Bcl-2 Pathways

Daiying Zuo, F. Sun, Yumiao Liu, 2016, Neurotoxicity Research.

Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family

J. Neale, T. Bzdȩga, C. Profaci, 2011, Journal of neurochemistry.

5-(Furan-2-yl)-4-(3,4,5-trimethoxyphenyl)-3H-1,2-dithiol-3-one oxime (6f), a new synthetic compound, causes human ﬁbrosarcoma HT-1080 cell apoptosis by disrupting tubulin polymerisation and inducing G2/M arrest.

Daiying Zuo, Yingliang Wu, Jiwei Shen, 2017, International journal of oncology.

Silver nanoparticles induce SH-SY5Y cell apoptosis via endoplasmic reticulum- and mitochondrial pathways that lengthen endoplasmic reticulum-mitochondria contact sites and alter inositol-3-phosphate receptor function.

Daiying Zuo, Zi Liu, Xuejiao Zhou, 2018, Toxicology letters.

Effects of N-Acetylaspartylglutamate (NAAG) Peptidase Inhibition on Release of Glutamate and Dopamine in Prefrontal Cortex and Nucleus Accumbens in Phencyclidine Model of Schizophrenia*

J. Neale, J. Moffett, T. Bzdȩga, 2012, The Journal of Biological Chemistry.

Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors.

Xin A. Zhang, Daiying Zuo, Qi Guan, 2022, Bioorganic & medicinal chemistry.

Construction of crizotinib resistant models with CD74-ROS1 D2033N and CD74-ROS1 S1986F point mutations to explore resistance mechanism and treatment strategy.

Daiying Zuo, Zengqiang Li, Xiaobo Xu, 2022, Cellular signalling.

Conformation impacts on the bioactivities of SMART analogues.

Kai Bao, Daiying Zuo, Qi Guan, 2018, European journal of medicinal chemistry.

Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities.

Kai Bao, Daiying Zuo, Zengqiang Li, 2014, European journal of medicinal chemistry.

Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold.

Kai Bao, Daiying Zuo, Yingliang Wu, 2017, European journal of medicinal chemistry.

Ultrasound-promoted two-step synthesis of 3-arylselenylindoles and 3-arylthioindoles as novel combretastatin A-4 analogues

Xiaona Li, Kai Bao, Daiying Zuo, 2016, Scientific Reports.

Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1.

X. Zhai, Daiying Zuo, P. Gong, 2016, European journal of medicinal chemistry.

Overcoming resistance to mitochondrial apoptosis by BZML‐induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells

Daiying Zuo, Yingliang Wu, Xiaobo Xu, 2018, Cell proliferation.

MAY, a novel tubulin inhibitor, induces cell apoptosis in A549 and A549/Taxol cells and inhibits epithelial-mesenchymal transition in A549/Taxol cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2020, Chemico-biological interactions.

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer.

Zhiyan Jiang, Q. Guo, Daiying Zuo, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2020, Toxicology in vitro : an international journal published in association with BIBRA.

The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy.

Daiying Zuo, Zi Liu, Yingliang Wu, 2021, European journal of pharmacology.

Recent advances and challenges of immune checkpoint inhibitors in immunotherapy of non-small cell lung cancer.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2020, International immunopharmacology.

Synthesis, biological evaluation and molecular modeling of imidazo[1,2-a]pyridine derivatives as potent antitubulin agents.

X. Zhai, Daiying Zuo, Lingyun Xing, 2017, Bioorganic & medicinal chemistry.

Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.

Kai Bao, Daiying Zuo, Yingliang Wu, 2020, Bioorganic chemistry.

Design, synthesis and structure-activity relationship of 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as novel tubulin inhibitors

Kai Bao, Daiying Zuo, Yingliang Wu, 2017, Scientific Reports.

Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors.

X. Zhai, Daiying Zuo, Jing Yang, 2021, Bioorganic & medicinal chemistry.

Design, synthesis and biological evaluation of 3,4-diaryl-1,2,5-oxadiazole-2/5-oxides as highly potent inhibitors of tubulin polymerization.

Kai Bao, Daiying Zuo, Yingliang Wu, 2019, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers

Kai Bao, Daiying Zuo, Zi Liu, 2021, Journal of enzyme inhibition and medicinal chemistry.

Synthesis and Biological Evaluations of 1,2‐Diaryl Pyrroles as Analogues of Combretastatin A‐4

Chunjian Liu, Kai Bao, Daiying Zuo, 2015, Chemical biology & drug design.

DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080

Xueqi Shen, Daiying Zuo, Yingliang Wu, 2012, Cancer Chemotherapy and Pharmacology.

Berberine acutely inhibits the digestion of maltose in the intestine.

Daiying Zuo, Ying-liang Wu, Huan Qi, 2012, Journal of ethnopharmacology.

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

3-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,2,5-selenadiazole (G-1103), a novel combretastatin A-4 analog, induces G2/M arrest and apoptosis by disrupting tubulin polymerization in human cervical HeLa cells and fibrosarcoma HT-1080 cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2015, Chemico-biological interactions.

PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma.

Yingshi Zhang, Qingchun Zhao, Daiying Zuo, 2020, Pharmacological research.

ZX-29, a novel ALK inhibitor, induces apoptosis via ER stress in ALK rearrangement NSCLC cells and overcomes cell resistance caused by an ALK mutation.

X. Zhai, Daiying Zuo, Xuejiao Zhou, 2020, Biochimica et biophysica acta. Molecular cell research.

EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2022, Cellular signalling.

BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.

Daiying Zuo, Yingliang Wu, Qi Guan, 2017, Cancer letters.

T-2 toxin induces apoptosis in differentiated murine embryonic stem cells through reactive oxygen species-mediated mitochondrial pathway

S. Peng, Jiabin Guo, Daiying Zuo, 2012, Apoptosis.

Structure-based optimization identified novel furyl-containing 2,4-diarylaminopyrimidine analogues as ALK/ROS1 dual inhibitors with anti-mutation effects.

X. Zhai, Daiying Zuo, Ming-juan Guo, 2021, European journal of medicinal chemistry.

1‐(4‐((5‐chloro‐4‐((2‐(isopropylsulfonyl)phenyl)amino)pyrimidin‐2‐yl)amino)‐3‐methoxyphenyl)‐3‐(2‐(dimethylamino)ethyl)imidazolidin‐2‐one (ZX‐42), a novel ALK inhibitor, induces apoptosis and protective autophagy in H2228 cells

X. Zhai, Daiying Zuo, Yingliang Wu, 2020, The Journal of pharmacy and pharmacology.

Structure-based design of 2,4-diaminopyrimidine derivatives bearing a pyrrolyl group as ALK and ROS1 inhibitors

X. Zhai, Nan Jiang, Daiying Zuo, 2020 .

Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer

Daiying Zuo, Yingliang Wu, Xiaobo Xu, 2019, Cancer Chemotherapy and Pharmacology.

Dual potent ALK and ROS1 inhibitors combating drug-resistant mutants: Synthesis and biological evaluation of aminopyridine-containing diarylaminopyrimidine derivatives.

X. Zhai, Junlong Zhang, Nan Jiang, 2018, European journal of medicinal chemistry.

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2018, Cancer biology & therapy.

Metastasis manners and the underlying mechanisms of ALK and ROS1 rearrangement lung cancer and current possible therapeutic strategies

Daiying Zuo, Zi Liu, Zengqiang Li, 2019, RSC advances.

Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.

Jiayi Cai, Daiying Zuo, Zengqiang Li, 2014, Chemical & pharmaceutical bulletin.

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2016, Cancer letters.

NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation

J. Neale, J. Moffett, T. Bzdȩga, 2012, Molecular pain.

In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor

Jingwei Tian, Y. Xing, Daiying Zuo, 2015, Physiology & Behavior.

A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers

Daiying Zuo, Zi Liu, Zengqiang Li, 2022, The Journal of biological chemistry.

Discovery of novel mutant-combating ALK and ROS1 dual inhibitors bearing imidazolidin-2-one moiety with reasonable PK properties.

X. Zhai, Nan Jiang, Daiying Zuo, 2019, European journal of medicinal chemistry.

A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA

J. Neale, J. Moffett, Daiying Zuo, 2017, Molecular pain.

Baicalin Attenuates Ketamine-Induced Neurotoxicity in the Developing Rats: Involvement of PI3K/Akt and CREB/BDNF/Bcl-2 Pathways

Daiying Zuo, F. Sun, Yumiao Liu, 2016, Neurotoxicity Research.

FAT4 activation inhibits epithelial-mesenchymal transition (EMT) by promoting autophagy in H2228/Cer cells

Daiying Zuo, Zi Liu, Zengqiang Li, 2022, Medical Oncology.

ZYY-B-2, a novel ALK inhibitor, overcomes resistance to ceritinib by inhibiting P-gp function and induces apoptosis through mitochondrial pathway in ceritinib-resistant H2228 cells.

X. Zhai, Keyan Sun, Daiying Zuo, 2023, Chemico-biological interactions.

The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-D-glucose.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2022, Chemico-biological interactions.

Correction to: YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2020, Toxicology in vitro : an international journal published in association with BIBRA.

Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R.

X. Zhai, Yucheng Gu, Daiying Zuo, 2018, European journal of medicinal chemistry.

Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer.

Hongying Wu, Daiying Zuo, Yingliang Wu, 2022, Cancer letters.

Presynaptic Mechanism Fiber-CA3 Synaptic Neurotransmission by a GCP II (NAALADase) Inhibition Suppresses Mossy

D. Manahan‐Vaughan, U. Heinemann, J. Neale, 2015 .

5-chloro-N4-(2-(isopropylsulfonyl)phenyl)-N2-(2-methoxy-4-(4-((4-methylpiperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)phenyl)pyrimidine-2,4-diamine (WY-135), a novel ALK inhibitor, induces cell cycle arrest and apoptosis through inhibiting ALK and its downstream pathways in Karpas299 and H2228 cells.

X. Zhai, Daiying Zuo, Zengqiang Li, 2018, Chemico-biological interactions.

2‐Methoxy‐5((3,4,5‐trimethosyphenyl) seleninyl) phenol causes G2/M cell cycle arrest and apoptosis in NSCLC cells through mitochondrial apoptotic pathway and MDM2 inhibition

Bolin Liu, Jiang Bian, Daiying Zuo, 2022, Journal of biochemical and molecular toxicology.

A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a nude mouse xenograft model and induces protective autophagy.

X. Zhai, Daiying Zuo, Xuejiao Zhou, 2019, Toxicology and applied pharmacology.

An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects.

X. Zhai, Daiying Zuo, Ming-juan Guo, 2019, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of 4,6-diphenyl-2-(1H-pyrrol-1-yl)nicotinonitrile analogues of crolibulin and combretastatin A-4.

Daiying Zuo, Deyu Sun, Yajing Liu, 2018, European journal of medicinal chemistry.

Discovery and optimization of tetrahydropyrido[4,3-d]pyrimidine derivatives as novel ATX and EGFR dual inhibitors.

X. Zhai, Junlong Zhang, Daiying Zuo, 2018, Bioorganic & medicinal chemistry.

Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.

Qiang Yang, Yang Li, Xiucai Ding, 2023, Biochemical pharmacology.

Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

S. Jiao, Daiying Zuo, Yiliang Li, 2022, Frontiers in Pharmacology.

Resistance mechanisms and potent-targeted therapies of ROS1-positive lung cancer

Daiying Zuo, Yingliang Wu, Xiaobo Xu, 2019, Cancer Chemotherapy and Pharmacology.

Microwave-assisted synthesis, molecular docking and antiproliferative activity of (3/5-aryl-1,2,4-oxadiazole-5/3-yl)(3,4,5-trimethoxyphenyl)methanone oxime derivatives

Kai Bao, Daiying Zuo, Yingliang Wu, 2015 .

CD74–ROS1 L2026M mutant enhances autophagy through the MEK/ERK pathway to promote invasion, metastasis and crizotinib resistance in non‐small cell lung cancer cells

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2023, The FEBS journal.

Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies

Daiying Zuo, Ye Li, Xue Zhang, 2024, Frontiers in pharmacology.

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.

Daiying Zuo, Zengqiang Li, Yingliang Wu, 2020, Chemico-biological interactions.

SIRT1 silencing promotes EMT and Crizotinib resistance by regulating autophagy through AMPK/mTOR/S6K signaling pathway in EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung cancer cells.

Daiying Zuo, Zengqiang Li, Yuying Yang, 2024, Molecular carcinogenesis.

The Assessment of Fatty Acid Composition in Deep-Fried Dough Sticks across Five Cities in China in 2020

Daiying Zuo, Sana Liu, H. Fang, 2023, Processes.